得保達明注射液
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DOBUTAMINE (HCL)
Available from:
恆振企業有限公司 台北巿永吉路３０２號４Ｆ之２ (14078416)
Pharmaceutical form:
注射劑
Composition:
DOBUTAMINE (HCL) (2404309210) 14.01MG
Units in package:
小瓶;;盒裝
Class:
製 劑
Prescription type:
限由醫師使用
Manufactured by:
DAVID BULL LABORATORIES 7-23 LEXIA PLACE, MULGRAVE VICTORIA 3170,AUSTRALIA AU
Therapeutic indications:
增強心肌收縮力而適用於短期治療器質性心臟病、心臟外科手術引起心肌收縮力抑制而導致之心臟代償機能衰竭
Product summary:
註銷日期: 1997/11/28; 註銷理由: 賦形劑變更;;移轉（申請商）;;製造廠地址變更;;製造廠名稱變更; 有效日期: 2000/08/02; 英文品名: DOBUTAMINE HYDROCHLORIDE INJECTION "DBL"
Authorization status:
已註銷
Authorization date:
1995-08-02
